Senseonics Holdings (SENS) risk factors

73 risks, 10 new, 9 dropped, 12 reworded since the prior year. Senseonics resumed direct commercial responsibility for Eversense in the U.S. and Europe, increasing operating expenses and hiring former Ascensia personnel.

72 risks. The company relies heavily on Ascensia to commercialize its single product, Eversense, creating high vulnerability if sales falter. Accumulated deficits of $947.9 million raise going concern doubts and necessitate careful debt management. Compliance with stringent regulations and protection of 482 patents are vital for future viability.